Evaluation of immunomodulator effect with lymphopenia and other side effects in relapsing-remitting multiple sclerosis patients using fingolimod: Clinical data preliminary results

dc.contributor.authorGuler, S.
dc.date.accessioned2024-06-12T11:20:29Z
dc.date.available2024-06-12T11:20:29Z
dc.date.issued2017
dc.departmentTrakya Üniversitesien_US
dc.description23rd World Congress of Neurology (WCN) -- SEP 16-21, 2017 -- Kyoto, JAPANen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipWorld Federat Neurolen_US
dc.identifier.doi10.1016/j.jns.2017.08.3446
dc.identifier.endpage437en_US
dc.identifier.issn0022-510X
dc.identifier.issn1878-5883
dc.identifier.startpage437en_US
dc.identifier.urihttps://doi.org/10.1016/j.jns.2017.08.3446
dc.identifier.urihttps://hdl.handle.net/20.500.14551/25636
dc.identifier.volume381en_US
dc.identifier.wosWOS:000427450301432en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherElsevier Science Bven_US
dc.relation.ispartofJournal Of The Neurological Sciencesen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keywords]en_US
dc.titleEvaluation of immunomodulator effect with lymphopenia and other side effects in relapsing-remitting multiple sclerosis patients using fingolimod: Clinical data preliminary resultsen_US
dc.typeConference Objecten_US

Dosyalar